129 related articles for article (PubMed ID: 1287831)
21. Low-dose heparin versus full-dose heparin with high-dose aprotinin during cardiopulmonary bypass. A preliminary report.
von Segesser LK; Garcia E; Turina MI
Tex Heart Inst J; 1993; 20(1):28-32. PubMed ID: 7685221
[TBL] [Abstract][Full Text] [Related]
22. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
Francalancia NA; Aeba R; Yousem SA; Griffith BP; Marrone GC
J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
[TBL] [Abstract][Full Text] [Related]
23. Effect of low-dose aprotinin on coagulation and fibrinolysis in cardiopulmonary bypass.
Kawasuji M; Ueyama K; Sakakibara N; Tedoriya T; Matsunaga Y; Misaki T; Watanabe Y
Ann Thorac Surg; 1993 May; 55(5):1205-9. PubMed ID: 7684219
[TBL] [Abstract][Full Text] [Related]
24. [The evaluation of the bio-compatibility and the clinical usefulness of heparin-coated cardiopulmonary bypass circuits].
Yamanaka J; Takeuchi Y; Torii S; Gomi A; Nakatani H; Kohno K
Nihon Kyobu Geka Gakkai Zasshi; 1996 Jan; 44(1):47-53. PubMed ID: 8683171
[TBL] [Abstract][Full Text] [Related]
25. [The significance of heparin concentration measurement during cardiopulmonary bypass--effect of heparin-coated circuit during normothermic bypass].
Komiya T; Ban K; Yamazaki K; Ishii O; Nakamura T; Kanzaki Y
Nihon Kyobu Geka Gakkai Zasshi; 1997 Nov; 45(11):1810-5. PubMed ID: 9430957
[TBL] [Abstract][Full Text] [Related]
26. Coagulofibrinolysis during heparin-coated cardiopulmonary bypass with reduced heparinization.
Kumano H; Suehiro S; Hattori K; Shibata T; Sasaki Y; Hosono M; Kinoshita H
Ann Thorac Surg; 1999 Oct; 68(4):1252-6. PubMed ID: 10543488
[TBL] [Abstract][Full Text] [Related]
27. Effects of tranexamic acid on postoperative bleeding and related hematochemical variables in coronary surgery: Comparison between on-pump and off-pump techniques.
Casati V; Della Valle P; Benussi S; Franco A; Gerli C; Baili P; Alfieri O; D'Angelo A
J Thorac Cardiovasc Surg; 2004 Jul; 128(1):83-91. PubMed ID: 15224025
[TBL] [Abstract][Full Text] [Related]
28. Closed, phosphorylcholine-coated circuit and reduction of systemic heparinization for cardiopulmonary bypass: the intraoperative ECMO concept.
Ranucci M; Pazzaglia A; Isgrò G; Cazzaniga A; Ditta A; Boncilli A; Cotza M; Carboni G; Brozzi S; Bonifazi C
Int J Artif Organs; 2002 Sep; 25(9):875-81. PubMed ID: 12403404
[TBL] [Abstract][Full Text] [Related]
29. Surface-bound heparin fails to reduce thrombin formation during clinical cardiopulmonary bypass.
Gorman RC; Ziats N; Rao AK; Gikakis N; Sun L; Khan MM; Stenach N; Sapatnekar S; Chouhan V; Gorman JH; Niewiarowski S; Colman RW; Anderson JM; Edmunds LH
J Thorac Cardiovasc Surg; 1996 Jan; 111(1):1-11; discussion 11-2. PubMed ID: 8551753
[TBL] [Abstract][Full Text] [Related]
30. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
Ovrum E; Am Holen E; Tangen G; Ringdal MA
Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
[TBL] [Abstract][Full Text] [Related]
31. Use of heparin-coated cardiopulmonary bypass circuit with low-dose heparin reduces postoperative bleeding.
Suehiro S; Shibata T; Sasaki Y; Hattori K; Kumano H; Hosono M; Kinoshita H
Ann Thorac Cardiovasc Surg; 1999 Aug; 5(4):225-9. PubMed ID: 10508946
[TBL] [Abstract][Full Text] [Related]
32. A randomized study of coronary artery bypass surgery performed with the Resting Heart™ System utilizing a low vs a standard dosage of heparin.
Nilsson J; Scicluna S; Malmkvist G; Pierre L; Algotsson L; Paulsson P; Bjursten H; Johnsson P
Interact Cardiovasc Thorac Surg; 2012 Nov; 15(5):834-9. PubMed ID: 22914806
[TBL] [Abstract][Full Text] [Related]
33. Prevention of postbypass bleeding with tranexamic acid and epsilon-aminocaproic acid.
Karski JM; Teasdale SJ; Norman PH; Carroll JA; Weisel RD; Glynn MF
J Cardiothorac Vasc Anesth; 1993 Aug; 7(4):431-5. PubMed ID: 8104526
[TBL] [Abstract][Full Text] [Related]
34. Comparison of two doses of heparin on outcome in off-pump coronary artery bypass surgery patients: A prospective randomized control study.
Chakravarthy M; Prabhakumar D; Thimmannagowda P; Krishnamoorthy J; George A; Jawali V
Ann Card Anaesth; 2017; 20(1):8-13. PubMed ID: 28074788
[TBL] [Abstract][Full Text] [Related]
35. Do surface modifying additives (SMA) influence blood loss and thrombogenicity in conventional cardiopulmonary bypass for coronary artery bypass grafting?
Martens S; Matheis G; Wimmer-Greinecker G; Scherer M; Doss M; Moritz A
Cardiovasc Surg; 2003 Apr; 11(2):159-63. PubMed ID: 12664053
[TBL] [Abstract][Full Text] [Related]
36. Reduced blood loss and transfusion requirements with low systemic heparinization: preliminary clinical results in coronary artery revascularization.
von Segesser LK; Weiss BM; Garcia E; Gallino A; Turina M
Eur J Cardiothorac Surg; 1990; 4(12):639-43. PubMed ID: 2288743
[TBL] [Abstract][Full Text] [Related]
37. Argatroban as a potential anticoagulant in cardiopulmonary bypass-studies in a dog model.
Sakai M; Ohteki H; Narita Y; Naitoh K; Natsuaki M; Itoh T
Cardiovasc Surg; 1999 Mar; 7(2):187-94. PubMed ID: 10353669
[TBL] [Abstract][Full Text] [Related]
38. Changes in platelet, granulocyte, and complement activation during cardiopulmonary bypass using heparin-coated equipment.
Fukutomi M; Kobayashi S; Niwaya K; Hamada Y; Kitamura S
Artif Organs; 1996 Jul; 20(7):767-76. PubMed ID: 8828766
[TBL] [Abstract][Full Text] [Related]
39. Heparin-coated circuit in coronary surgery. A clinical study.
Sáenz A; Larrañaga G; Alvarez L; Greco E; Marrero A; Lunar M; Elósegui C; Ubago JL; Gallo I
Eur J Cardiothorac Surg; 1996; 10(1):48-53. PubMed ID: 8776185
[TBL] [Abstract][Full Text] [Related]
40. Low-dose and high-dose aprotinin improve hemostasis in coronary operations.
Speekenbrink RG; Wildevuur CR; Sturk A; Eijsman L
J Thorac Cardiovasc Surg; 1996 Aug; 112(2):523-30. PubMed ID: 8751522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
